- Home
- MRK vs WFC Comparison
MRK vs WFC Comparison
Compare MRK & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | WFC |
|---|---|---|
| Founded | 2000 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 290.6B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | WFC |
|---|---|---|
| Price | $119.51 | $81.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 16 |
| Target Price | ★ $123.21 | $97.37 |
| AVG Volume (30 Days) | 11.1M | ★ 13.6M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.80% | 2.18% |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.66 | $11.46 |
| Revenue Next Year | $5.28 | $4.55 |
| P/E Ratio | $16.69 | ★ $14.15 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $58.42 |
| 52 Week High | $125.14 | $97.76 |
Technical Indicators
Market Signals| Indicator | MRK | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 53.97 | 35.59 |
| Support Level | $76.90 | $81.05 |
| Resistance Level | N/A | $85.22 |
| Average True Range (ATR) | 2.62 | 2.89 |
| MACD | -0.57 | -0.68 |
| Stochastic Oscillator | 38.90 | 19.09 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $2.1 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.